Paper32915331
The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity.
Ayuna A and 1 other. Egypt Heart J, 2020. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity. Papers, record 32915331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32915331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11928719 | Beneficial effects of angiotensin-converting enzyme inhibition in adriamycin-induced cardiomyopathy in hamsters. | Jpn J Pharmacol | 2002 | https://conductscience.org/library/papers/11928719 | PubMed |
| 2 | 30595329 | Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin. | Indian Heart J | 2018 | https://conductscience.org/library/papers/30595329 | PubMed |
| 3 | 27893331 | Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/27893331 | PubMed |
| 4 | 20872550 | Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up. | Am J Hematol | 2010 | https://conductscience.org/library/papers/20872550 | PubMed |
| 5 | 17161256 | Protective effects of carvedilol against anthracycline-induced cardiomyopathy. | J Am Coll Cardiol | 2006 | https://conductscience.org/library/papers/17161256 | PubMed |
| 6 | 27567406 | 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). | Eur Heart J | 2016 | https://conductscience.org/library/papers/27567406 | PubMed |
| 7 | 27351173 | Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma. | Cancer | 2016 | https://conductscience.org/library/papers/27351173 | PubMed |
| 8 | 30009543 | Role of ACE inhibitors in anthracycline-induced cardiotoxicity: A randomized, double-blind, placebo-controlled trial. | Pediatr Blood Cancer | 2018 | https://conductscience.org/library/papers/30009543 | PubMed |
| 9 | 28141699 | Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity. | J Cardiovasc Pharmacol | 2017 | https://conductscience.org/library/papers/28141699 | PubMed |
| 10 | 10933366 | Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. | J Am Coll Cardiol | 2000 | https://conductscience.org/library/papers/10933366 | PubMed |
| 11 | 29540327 | Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY Trial. | J Am Coll Cardiol | 2018 | https://conductscience.org/library/papers/29540327 | PubMed |
| 12 | 9768828 | Epidemiology of anthracycline cardiotoxicity in children and adults. | Semin Oncol | 1998 | https://conductscience.org/library/papers/9768828 | PubMed |
| 13 | 17101852 | Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. | Circulation | 2006 | https://conductscience.org/library/papers/17101852 | PubMed |
| 14 | 23583763 | Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies). | J Am Coll Cardiol | 2013 | https://conductscience.org/library/papers/23583763 | PubMed |
| 15 | 22727976 | Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study. | Int J Cardiol | 2013 | https://conductscience.org/library/papers/22727976 | PubMed |
| 16 | 27918725 | Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/27918725 | PubMed |
| 17 | 15148277 | Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. | Circulation | 2004 | https://conductscience.org/library/papers/15148277 | PubMed |
| 18 | 20826257 | Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment. | Am Heart J | 2010 | https://conductscience.org/library/papers/20826257 | PubMed |
| 19 | 17070141 | Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. | Am Heart J | 2006 | https://conductscience.org/library/papers/17070141 | PubMed |
| 20 | 29118031 | Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study. | J Am Heart Assoc | 2017 | https://conductscience.org/library/papers/29118031 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40970189 | Pharmacological interventions to prevent cardiotoxicity in patients undergoing anthracycline-based chemotherapy: a network meta-analysis. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40970189 | PubMed |
| 40387994 | Evaluation of left atrial strain changes in patients with breast cancer after anthracycline therapy. | Egypt Heart J | 2025 | https://conductscience.org/library/papers/40387994 | PubMed |
| 40207253 | Comprehensive review of non-invasive-treatment-related cardiovascular toxicity in breast cancer. | iScience | 2025 | https://conductscience.org/library/papers/40207253 | PubMed |
| 37875715 | Mesenchymal Stem Cell-Derived Exosomes and Their MicroRNAs in Heart Repair and Regeneration. | J Cardiovasc Transl Res | 2024 | https://conductscience.org/library/papers/37875715 | PubMed |
| 35757327 | Clinical Manifestations, Monitoring, and Prognosis: A Review of Cardiotoxicity After Antitumor Strategy. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35757327 | PubMed |
| 35497981 | Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35497981 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE | 1636 | PubTator's text mining | https://conductscience.org/library/genes/1636 | NCBI Gene |
| CMPK1 | 51727 | PubTator's text mining | https://conductscience.org/library/genes/51727 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| NPPB | 4879 | PubTator's text mining | https://conductscience.org/library/genes/4879 | NCBI Gene |
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 | NCBI Gene |
| TNNI3 | 7137 | PubTator's text mining | https://conductscience.org/library/genes/7137 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32915331
GET https://conductscience.org/api/papers/v1/32915331/references?page=2